What is the share price of Prism Medico and Pharmacy Ltd (PRISMMEDI) today?
The share price of PRISMMEDI as on 30th June 2025 is ₹14.70. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Prism Medico and Pharmacy Ltd (PRISMMEDI) share?
The past returns of Prism Medico and Pharmacy Ltd (PRISMMEDI) share are- Past 1 week: -4.63%
- Past 1 month: -11.56%
- Past 3 months: 25.43%
- Past 6 months: -40.61%
- Past 1 year: -39.75%
- Past 3 years: 68.00%
- Past 5 years: 4.85%
What are the peers or stocks similar to Prism Medico and Pharmacy Ltd (PRISMMEDI)?
The peers or stocks similar to Prism Medico and Pharmacy Ltd (PRISMMEDI) include:What is the market cap of Prism Medico and Pharmacy Ltd (PRISMMEDI) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Prism Medico and Pharmacy Ltd (PRISMMEDI) is ₹8.91 Cr as of 30th June 2025.What is the 52 week high and low of Prism Medico and Pharmacy Ltd (PRISMMEDI) share?
The 52-week high of Prism Medico and Pharmacy Ltd (PRISMMEDI) is ₹37.20 and the 52-week low is ₹11.62.What is the PE and PB ratio of Prism Medico and Pharmacy Ltd (PRISMMEDI) stock?
The P/E (price-to-earnings) ratio of Prism Medico and Pharmacy Ltd (PRISMMEDI) is -222.83. The P/B (price-to-book) ratio is 0.59.Which sector does Prism Medico and Pharmacy Ltd (PRISMMEDI) belong to?
Prism Medico and Pharmacy Ltd (PRISMMEDI) belongs to the Consumer Staples sector & Agro Products sub-sector.How to buy Prism Medico and Pharmacy Ltd (PRISMMEDI) shares?
You can directly buy Prism Medico and Pharmacy Ltd (PRISMMEDI) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Prism Medico and Pharmacy Ltd
PRISMMEDI Share Price
14.705.00% (+0.70)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
PRISMMEDI Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
PRISMMEDI Performance & Key Metrics
PRISMMEDI Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -178.26 | 0.59 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.73 | 9.52 | 1.03% |
PRISMMEDI Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
PRISMMEDI Company Profile
Prism Medico and Pharmacy is engaged in wholesale and retail of straw, fodder & other animal/poultry feed technology
GODREJAGRO
PE Ratio
34.98
34.98
1Y Return
4.10%
4.10%
Buy Reco %
80.00
80.00
PE Ratio
20.53
20.53
1Y Return
18.29%
18.29%
Buy Reco %
100.00
100.00
PE Ratio
29.44
29.44
1Y Return
13.53%
13.53%
Buy Reco %
0.00
0.00
BNHOLDINGS
PE Ratio
111.09
111.09
1Y Return
49.60%
49.60%
Buy Reco %
0.00
0.00
SANSTAR
PE Ratio
43.66
43.66
1Y Return
8.85%
8.85%
Buy Reco %
0.00
0.00
PRISMMEDI Forecast
PRISMMEDI Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
PRISMMEDI
PRISMMEDI
Income
Balance Sheet
Cash Flow
Annual Normal View
PRISMMEDI Income Statement
PRISMMEDI Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.16 | 20.96 | 36.53 | 26.89 | 16.76 | 8.44 | 1.27 | 3.05 | 0.65 | 0.64 | ||||||||||
Raw Materials | 0.79 | 20.73 | 35.28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.71 | 0.71 | ||||||||||
| Power & Fuel Cost | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||
| Employee Cost | 0.01 | 0.10 | 0.25 | 0.22 | 0.17 | 0.19 | 0.05 | 0.03 | ||||||||||||
| Selling & Administrative Expenses | 0.00 | 0.13 | 0.41 | 0.11 | 0.09 | 0.12 | 0.11 | 0.41 | ||||||||||||
| Operating & Other expenses | -0.44 | -0.09 | 0.26 | 26.61 | 16.67 | 8.63 | 1.21 | 2.62 | ||||||||||||
EBITDA | -0.20 | 0.09 | 0.33 | -0.05 | -0.17 | -0.50 | -0.10 | -0.01 | -0.06 | -0.07 | ||||||||||
| Depreciation/Amortization | 0.02 | 0.04 | 0.03 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | — | ||||||||||
| PBIT | -0.22 | 0.05 | 0.30 | -0.07 | -0.18 | -0.51 | -0.11 | -0.02 | -0.06 | -0.07 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | — | ||||||||||
| PBT | -0.22 | 0.05 | 0.30 | -0.07 | -0.18 | -0.51 | -0.11 | -0.03 | -0.06 | -0.07 | ||||||||||
| Taxes & Other Items | 0.00 | 0.07 | -0.07 | -0.02 | -0.05 | -0.13 | -0.03 | -0.01 | -0.02 | -0.02 | ||||||||||
| Net Income | -0.22 | -0.02 | 0.37 | -0.05 | -0.13 | -0.38 | -0.08 | -0.02 | -0.04 | -0.05 | ||||||||||
| EPS | -0.55 | -0.03 | 0.61 | -0.08 | -0.21 | -0.63 | -0.13 | -0.03 | 0.00 | -0.08 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 |
PRISMMEDI Company Updates
PRISMMEDI Stock Peers
PRISMMEDI Past Performance & Peer Comparison
PRISMMEDI Past Performance & Peer Comparison
Comparing 3 stocks from
Consumer StaplesAgro Products
Compare valuation-basic on Screener
Consumer StaplesAgro Products
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Prism Medico and Pharmacy Ltd | -222.83 | 0.59 | — |
| Godrej Agrovet Ltd | 34.98 | 5.15 | 1.41% |
| Gujarat Ambuja Exports Ltd | 20.53 | 1.84 | 0.22% |
| Jubilant Agri and Consumer Products Ltd | 29.44 | 11.23 | — |
PRISMMEDI Stock Price Comparison
Compare PRISMMEDI with any stock or ETFCompare PRISMMEDI with any stock or ETF
PRISMMEDI
PRISMMEDI Holdings
PRISMMEDI Shareholdings
PRISMMEDI Promoter Holdings Trend
PRISMMEDI Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
PRISMMEDI Institutional Holdings Trend
PRISMMEDI Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
PRISMMEDI Shareholding Pattern
PRISMMEDI Shareholding Pattern
PRISMMEDI Shareholding History
PRISMMEDI Shareholding History
Mutual Funds
smallcases containing PRISMMEDI stock
smallcases containing PRISMMEDI stock
Looks like this stock is not in any smallcase yet.
PRISMMEDI Events
PRISMMEDI Events
PRISMMEDI Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
PRISMMEDI has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
PRISMMEDI Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
PRISMMEDI has not given any dividends in last 5 years
PRISMMEDI Dividends
PRISMMEDI Dividends
Hmm, looks like data is unavailable here. Please come back after some timePRISMMEDI Stock News & Opinions
PRISMMEDI Stock News & Opinions
Articles & Videos
Earnings
Prism Medico & Pharmacy reports standalone net profit of Rs 0.04 crore in the March 2025 quarter
Net profit of Prism Medico & Pharmacy reported to Rs 0.04 crore in the quarter ended March 2025 as against net loss of Rs 0.07 crore during the previous quarter ended March 2024. Sales declined 53.33% to Rs 0.07 crore in the quarter ended March 2025 as against Rs 0.15 crore during the previous quarter ended March 2024. For the full year,net loss reported to Rs 0.05 crore in the year ended March 2025 as against net loss of Rs 0.02 crore during the previous year ended March 2024. Sales declined 78.50% to Rs 0.63 crore in the year ended March 2025 as against Rs 2.93 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales0.070.15 -53 0.632.93 -79 OPM %14.29-120.00 --14.29-4.44 - PBDT0.02-0.08 LP -0.07-0.02 -250 PBT0.02-0.08 LP -0.07-0.03 -133 NP0.04-0.07 LP -0.05-0.02 -150 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Prism Medico and Pharmacy to hold board meeting
Prism Medico and Pharmacy will hold a meeting of the Board of Directors of the Company on 28 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Prism Medico & Pharmacy reports standalone net loss of Rs 0.01 crore in the December 2024 quarter
Net loss of Prism Medico & Pharmacy reported to Rs 0.01 crore in the quarter ended December 2024 as against net profit of Rs 0.19 crore during the previous quarter ended December 2023. Sales declined 92.36% to Rs 0.21 crore in the quarter ended December 2024 as against Rs 2.75 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales0.212.75 -92 OPM %-4.766.91 - PBDT-0.010.19 PL PBT-0.010.19 PL NP-0.010.19 PL Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Prism Medico and Pharmacy to announce Quarterly Result
Prism Medico and Pharmacy will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Prism Medico & Pharmacy reports standalone net profit of Rs 0.01 crore in the September 2024 quarter
Net profit of Prism Medico & Pharmacy reported to Rs 0.01 crore in the quarter ended September 2024 as against net loss of Rs 0.05 crore during the previous quarter ended September 2023. Sales rose 866.67% to Rs 0.29 crore in the quarter ended September 2024 as against Rs 0.03 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales0.290.03 867 OPM %3.45-200.00 - PBDT0.01-0.05 LP PBT0.01-0.05 LP NP0.01-0.05 LP Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Prism Medico and Pharmacy to table results
Prism Medico and Pharmacy will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Prism Medico and Pharmacy AGM scheduled
Prism Medico and Pharmacy announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Prism Medico and Pharmacy to conduct board meeting
Prism Medico and Pharmacy will hold a meeting of the Board of Directors of the Company on 5 September 2024.Powered by Capital Market - Live
9 months agoCapital Market - Live
Earnings
Prism Medico & Pharmacy reports standalone net loss of Rs 0.09 crore in the June 2024 quarter
Net Loss of Prism Medico & Pharmacy reported to Rs 0.09 crore in the quarter ended June 2024 as against net loss of Rs 0.09 crore during the previous quarter ended June 2023. Sales reported to Rs 0.06 crore in the quarter ended June 2024. There were no Sales reported during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales0.060 0 OPM %-150.000 - PBDT-0.09-0.09 0 PBT-0.09-0.09 0 NP-0.09-0.09 0 Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Prism Medico and Pharmacy to hold board meeting
Prism Medico and Pharmacy will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live
10 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of -52.5%, vs industry avg of 7.21%
Over the last 5 years, market share decreased from 0.11% to 0%